Tenax Therapeutics GAAP EPS of -$0.40 beats by $0.72

* Tenax Therapeutics press release [https://seekingalpha.com/pr/20305061-tenax-therapeutics-reports-third-quarter-2025-financial-results-and-provides-corporate-update] (TENX [https://seekingalpha.com/symbol/TENX]): Q3 GAAP EPS of -$0.40 beats by $0.72.
* Tenax Therapeutics reported cash and cash equivalents of $99.4 million as of September 30, 2025. Tenax expects its cash and cash equivalents to fund the Company through 2027.

MORE ON TENAX THERAPEUTICS

* Seeking Alpha’s Quant Rating on Tenax Therapeutics [https://seekingalpha.com/symbol/TENX/ratings/quant-ratings]
* Historical earnings data for Tenax Therapeutics [https://seekingalpha.com/symbol/TENX/earnings]
* Financial information for Tenax Therapeutics [https://seekingalpha.com/symbol/TENX/income-statement]